New!
Portfolio
Login
/
Sign Up
Search
Industries
Technology
Energy
Media
Finance
Green Issues
China
All Concepts
Metals
Energy
Meats
Grains
Softs
ETFs
Indices
Currencies
Geographies
Exchanges
Rates
How To Invest
Personal Finance
Options 101
Definitions
close
close
close
close
Send us Feedback
Map Pharmaceuticals Inc (MAPP)
SUMMARY
BULLS
BEARS
TOPICS
DATA CENTRAL
STOCK CHART
SEC FILINGS
BALANCE
INCOME
CASH FLOW
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
Income Statement (USD)
Annual
|
Quarterly
QUARTER ENDING
30-SEP
2011
31-DEC
2011
31-MAR
2012
30-JUN
2012
30-SEP
2012
Total Revenue
23.9M
-38.5M
1.03M
878K
878K
Cost of Revenue
-421K
-420K
0
0
0
Gross Profit
24.3M
-38.0M
1.03M
878K
878K
Research & Development
6.72M
8.11M
11.0M
7.77M
7.86M
SG&A
5.89M
6.53M
7.91M
6.40M
5.64M
Amortization & Deprec
421K
420K
0
0
0
Other Expenses
-6000
-5000
0
-1000
0
Total Operating Expenses
13.0M
15.1M
18.9M
14.2M
13.5M
Operating Income
11.3M
-53.1M
-17.8M
-13.3M
-12.6M
Other Income
-2000
-20.0K
0
1000
-3000
EBIT
11.2M
-53.1M
-17.8M
-13.3M
-12.6M
Minority Interest
0
0
0
0
0
Interest Expense
43.0K
0
0
0
0
Income Before Taxes
11.2M
-53.1M
-17.8M
-13.3M
-12.6M
Income Taxes
0
0
0
0
0
Net Income from Continuing Ops
11.2M
-53.1M
-17.8M
-13.3M
-12.6M
Income - Discontinued Ops
0
0
0
0
0
Extraordinary Items
0
0
0
0
0
Effect of Accounting Changes
0
0
0
0
0
Other Items
0
0
0
0
0
Net Income
11.2M
-53.1M
-17.8M
-13.3M
-12.6M
Preferred Dividends
0
0
0
0
0
Net Income to Common
11.2M
-53.1M
-17.8M
-13.3M
-12.6M
Add Metric
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
Bet you've never seen portfolio analytics like these.
Introducing
SigFig
— from the creators of
Take Tour